STOCK TITAN

Cabot Corporation (CBT) Financials

CBT
Trailing 12 months to June 30, 2026
Revenue $3.6B -4.7% YoY
Net Income $190.0M -55.3% YoY
EPS (Diluted) $3.56 -53.4% YoY
Free Cash Flow $281.0M -19.3% YoY
Market Cap $3.9B as of Oct 10, 2026
Price / Sales 1.1x on $3.6B revenue, trailing 12 months to June 30, 2026
Price / Earnings 20.4x on $190.0M net income, trailing 12 months to June 30, 2026
Price / Book 2.4x on $1.6B equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 4, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CBT SEC filings page.

Cabot Corporation (CBT) reported $3.6B in revenue over the twelve months to Jun 30, 2026, down 4.7% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CBT FY2025

Cabot converts softer sales into higher operating margins while reinvesting heavily and steadily reducing balance-sheet leverage.

With sales lower in FY2025, operating margin widened from 15.4% to 16.7%, showing that improved operating economics offset a softer top line. Net margin nevertheless slipped in FY2025 as tax expense rose to $196M, so operating improvement did not fully reach shareholders.

Debt-to-equity fell from 0.8x to 0.6x, indicating deleveraging is strengthening the capital base. But the current ratio declined to 1.6x from 2.1x, so the improvement is long-term leverage rather than uniformly greater short-term liquidity.

Cash conversion remains positive, but free cash flow fell from $451M to $391M while operating cash flow stayed near the prior year, indicating reinvestment—not weaker cash generation—drove much of the change. Capital expenditures rose to $274M from $241M, absorbing more operating cash as sales softened.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 59 / 100
Financial Health Score 59/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cabot Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
77

Cabot Corporation has an operating margin of 16.7%, meaning the company retains $17 of operating profit per $100 of revenue. This strong profitability earns a score of 77/100, reflecting efficient cost management and pricing power. This is up from 15.4% the prior year.

Growth
21

Cabot Corporation's revenue declined 7.0% year-over-year, from $4.0B to $3.7B. This contraction results in a growth score of 21/100.

Leverage
53

Cabot Corporation has a moderate D/E ratio of 0.55. This balance of debt and equity financing earns a leverage score of 53/100.

Liquidity
46

Cabot Corporation's current ratio of 1.61 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow
67

Cabot Corporation converts 10.5% of revenue into free cash flow ($391.0M). This strong cash generation earns a score of 67/100.

Returns
90

Cabot Corporation earns a strong 21.3% return on equity (ROE), meaning it generates $21 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 90/100. This is down from 26.7% the prior year.

Altman Z-Score Safe
3.39

Cabot Corporation scores 3.39, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Cabot Corporation passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.01x

For every $1 of reported earnings, Cabot Corporation generates $2.01 in operating cash flow ($665.0M OCF vs $331.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
8.17x

Cabot Corporation earns $8.17 in operating income for every $1 of interest expense ($621.0M vs $76.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$982.0M
YoY+6.4%
QoQ+8.6%
5Y CAGR+1.4%
10Y CAGR+4.7%

Cabot Corporation generated $982.0M in revenue in Q3 2026. This represents an increase of 6.4% from the same quarter a year earlier. Against the prior quarter it is up 8.6%.

EBITDA
$148.0M
YoY-28.2%
QoQ-16.9%
5Y CAGR-3.2%

Cabot Corporation's EBITDA was $148.0M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 28.2% from the same quarter a year earlier. Against the prior quarter it is down 16.9%.

Net Income
$6.0M
YoY-94.1%
QoQ-91.2%
5Y CAGR-41.3%
10Y CAGR-20.0%

Cabot Corporation reported $6.0M in net income in Q3 2026. This represents a decrease of 94.1% from the same quarter a year earlier. Against the prior quarter it is down 91.2%.

EPS (Diluted)
$0.12
YoY-93.5%
QoQ-90.6%
5Y CAGR-39.5%
10Y CAGR-18.1%

Cabot Corporation earned $0.12 per diluted share (EPS) in Q3 2026. This represents a decrease of 93.5% from the same quarter a year earlier. Against the prior quarter it is down 90.6%.

Cash & Balance Sheet

Free Cash Flow
$37.0M
YoY-80.3%
QoQ+15.6%
5Y CAGR+8.2%
10Y CAGR-7.3%

Cabot Corporation generated $37.0M in free cash flow in Q3 2026, representing cash available after capex. This represents a decrease of 80.3% from the same quarter a year earlier. Against the prior quarter it is up 15.6%.

Cash & Debt
$250.0M
YoY+4.6%
QoQ-0.8%
5Y CAGR+7.6%
10Y CAGR+1.2%

Cabot Corporation held $250.0M in cash against $828.0M in long-term debt as of Q3 2026.

Dividends Per Share
$0.47
YoY+5.0%
QoQ+5.0%

Cabot Corporation paid $0.47 per share in dividends in Q3 2026. This represents an increase of 5.0% from the same quarter a year earlier. Against the prior quarter it is up 5.0%.

Shares Outstanding
52M
YoY-3.0%
QoQ0.0%
5Y CAGR-1.9%
10Y CAGR-1.9%

Cabot Corporation had 52M shares outstanding in Q3 2026. This represents a decrease of 3.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Margins & Returns

Gross Margin
18.7%
YoY-7.7pp
QoQ-4.5pp
5Y change-4.6pp
10Y change-7.0pp

Cabot Corporation's gross margin was 18.7% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is down 7.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.5 percentage points.

Operating Margin
10.0%
YoY-8.1pp
QoQ-4.3pp
5Y change-4.6pp

Cabot Corporation's operating margin was 10.0% in Q3 2026, reflecting core business profitability. This is down 8.1 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.3 percentage points.

Net Margin
0.6%
YoY-10.3pp
QoQ-6.9pp
5Y change-8.8pp
10Y change-8.4pp

Cabot Corporation's net profit margin was 0.6% in Q3 2026, showing the share of revenue converted to profit. This is down 10.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 6.9 percentage points.

Return on Equity
0.4%
YoY-6.2pp
QoQ-4.0pp
5Y change-8.6pp
10Y change-4.0pp

Cabot Corporation's ROE was 0.4% in Q3 2026, measuring profit generated per dollar of shareholder equity. This is down 6.2 percentage points from the same quarter a year earlier. Against the prior quarter it is down 4.0 percentage points.

Capital Allocation

R&D Spending
$13.0M
YoY-13.3%
QoQ-7.1%
5Y CAGR+1.6%

Cabot Corporation invested $13.0M in research and development in Q3 2026. This represents a decrease of 13.3% from the same quarter a year earlier. Against the prior quarter it is down 7.1%.

Share Buybacks
$0
YoY-100.0%
QoQ-100.0%

Cabot Corporation repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.

Capital Expenditures
$38.0M
YoY-37.7%
QoQ-15.6%
5Y CAGR-3.7%
10Y CAGR+3.1%

Cabot Corporation invested $38.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 37.7% from the same quarter a year earlier. Against the prior quarter it is down 15.6%.

CBT Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CBT quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$982.0M+6.4%$904.0M-3.4%$849.0M-11.1%$899.0M-10.2%$923.0M-9.2%$936.0M-8.1%$955.0M-0.3%$1.0B+3.7%
Cost of Revenue$798.0M+17.5%$694.0M-0.1%$638.0M-11.4%$679.0M-10.8%$679.0M-10.7%$695.0M-10.1%$720.0M-2.7%$761.0M+2.8%
Gross Profit$184.0M-24.6%$210.0M-12.9%$211.0M-10.2%$220.0M-8.3%$244.0M-4.7%$241.0M-2.0%$235.0M+7.8%$240.0M+6.7%
R&D Expenses$13.0M-13.3%$14.0M-6.7%$13.0M-7.1%$15.0M-11.8%$15.0M-6.3%$15.0M0.0%$14.0M-6.7%$17.0M+21.4%
SG&A Expenses$73.0M+17.7%$67.0M+4.7%$69.0M+4.5%$68.0M-6.8%$62.0M-8.8%$64.0M-14.7%$66.0M-1.5%$73.0M+5.8%
Operating Income$98.0M-41.3%$129.0M-20.4%$129.0M-16.8%$137.0M-8.7%$167.0M-2.9%$162.0M+3.8%$155.0M+14.0%$150.0M+5.6%
EBITDA$148.0M-28.2%$178.0M-11.0%$170.0M-11.5%$177.0M-5.3%$206.0M-1.0%$200.0M+3.6%$192.0M+8.5%$187.0M+4.5%
Interest Expense$18.0M-5.3%$18.0M-5.3%$18.0M0.0%$20.0M+5.3%$19.0M0.0%$19.0M-9.5%$18.0M-18.2%$19.0M-9.5%
Income Tax$46.0M+7.0%$44.0M-10.2%$37.0M-9.8%$63.0M+730.0%$43.0M+7.5%$49.0M+4.3%$41.0M+20.6%-$10.0M+91.5%
Net Income$6.0M-94.1%$68.0M-27.7%$73.0M-21.5%$43.0M-68.6%$101.0M-7.3%$94.0M+11.9%$93.0M+86.0%$137.0M-41.5%
EPS (Basic)$0.12-93.6%$1.27-25.7%$1.38-18.3%$0.80-67.3%$1.87-4.6%$1.71+14.0%$1.69+92.0%$2.45-40.4%
EPS (Diluted)$0.12-93.5%$1.27-24.9%$1.37-18.0%$0.80-66.9%$1.86-4.1%$1.69+13.4%$1.67+89.8%$2.42-40.7%
Diluted Shares (Avg)52M-3.3%52M-4.0%53M-3.8%N/A54M-3.4%54M-2.5%55M-1.4%N/A

CBT Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CBT quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$4.0B+3.6%$3.9B+3.0%$3.8B+3.2%$3.8B+2.1%$3.8B+7.2%$3.8B+5.2%$3.6B-1.4%$3.7B+3.7%
Current Assets$1.7B+5.8%$1.5B-3.5%$1.5B-2.6%$1.5B-4.1%$1.6B-1.1%$1.6B-0.1%$1.5B-11.6%$1.6B-1.3%
Cash & Equivalents$250.0M+4.6%$252.0M+18.3%$230.0M+25.7%$258.0M+15.7%$239.0M+21.3%$213.0M+3.4%$183.0M-25.0%$223.0M-6.3%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$566.0M+6.6%$522.0M-3.5%$503.0M-6.2%$504.0M-8.7%$531.0M-4.0%$541.0M-1.8%$536.0M-13.1%$552.0M-5.6%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$137.0M+3.0%$136.0M+6.3%$136.0M+7.1%$134.0M+0.8%$133.0M+0.8%$128.0M-6.6%$127.0M-8.0%$133.0M-0.7%
Total Liabilities$2.4B+3.2%$2.3B-1.2%$2.2B-4.1%$2.3B-2.0%$2.3B+2.8%$2.4B+5.7%$2.3B-3.8%$2.3B-1.2%
Current Liabilities$1.1B+53.4%$1.1B+30.6%$874.0M+17.0%$957.0M+24.0%$740.0M+3.2%$818.0M+13.9%$747.0M-10.0%$772.0M-6.1%
Non-Current Liabilities$1.2B-20.6%$1.3B-18.1%$1.3B-14.5%$1.3B-15.0%$1.6B+2.6%$1.5B+1.9%$1.5B-0.5%$1.5B+1.4%
Long-Term Debt$828.0M-25.1%$863.0M-20.8%$854.0M-21.6%$856.0M-21.3%$1.1B+2.0%$1.1B+0.2%$1.1B-0.8%$1.1B-0.6%
Total Equity$1.6B+4.2%$1.6B+9.9%$1.6B+15.3%$1.6B+8.8%$1.5B+14.5%$1.4B+4.4%$1.4B+2.8%$1.4B+12.7%
Retained Earnings$1.8B-1.2%$1.8B+1.8%$1.8B+3.6%$1.8B+5.8%$1.8B+10.1%$1.8B+10.5%$1.8B+12.0%$1.7B+10.2%

Not reported in any period shown, so not listed: Accounts Receivable.

CBT Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CBT quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$75.0M-69.9%$77.0M+5.5%$126.0M+1.6%$219.0M+7.4%$249.0M+20.3%$73.0M-58.5%$124.0M+18.1%$204.0M+47.8%
Depreciation & Amortization$50.0M+28.2%$49.0M+28.9%$41.0M+10.8%$40.0M+8.1%$39.0M+8.3%$38.0M+2.7%$37.0M-9.8%$37.0M0.0%
Stock-Based CompensationN/AN/A$3.0M-62.5%N/AN/AN/A$8.0M+33.3%N/A
Capital Expenditures$38.0M-37.7%$45.0M-37.5%$69.0M-10.4%$64.0M-30.4%$61.0M+17.3%$72.0M+67.4%$77.0M+42.6%$92.0M+17.9%
Free Cash Flow$37.0M-80.3%$32.0M+3100.0%$57.0M+21.3%$155.0M+38.4%$188.0M+21.3%$1.0M-99.2%$47.0M-7.8%$112.0M+86.7%
Investing Cash Flow-$38.0M+41.5%-$109.0M-55.7%-$69.0M+33.7%-$59.0M+33.7%-$65.0M-27.5%-$70.0M-70.7%-$104.0M-92.6%-$89.0M-18.7%
Financing Cash Flow-$49.0M+73.2%$53.0M+211.8%-$92.0M-283.3%-$146.0M-64.0%-$183.0M-39.7%$17.0M+110.2%-$24.0M+17.2%-$89.0M-178.1%
Dividends Paid$24.0M0.0%$24.0M+4.3%$24.0M0.0%$25.0M+4.2%$24.0M0.0%$23.0M0.0%$24.0M+9.1%$24.0M+4.3%
Share Buybacks$0-100.0%$49.0M+4.3%$52.0M+23.8%$39.0M-40.9%$40.0M-18.4%$47.0M+95.8%$42.0M+27.3%$66.0M+32.0%

CBT Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CBT quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin18.7%-7.7pp23.2%-2.5pp24.9%+0.2pp24.5%+0.5pp26.4%+1.2pp25.8%+1.6pp24.6%+1.9pp24.0%+0.7pp
Operating Margin10.0%-8.1pp14.3%-3.0pp15.2%-1.0pp15.2%+0.3pp18.1%+1.2pp17.3%+2.0pp16.2%+2.0pp15.0%+0.3pp
Net Margin0.6%-10.3pp7.5%-2.5pp8.6%-1.1pp4.8%-8.9pp10.9%+0.2pp10.0%+1.8pp9.7%+4.5pp13.7%-10.6pp
Return on Equity0.4%-6.2pp4.3%-2.3pp4.6%-2.2pp2.8%-6.8pp6.6%-1.6pp6.6%+0.4pp6.8%+3.0pp9.6%-8.9pp
Return on Assets0.1%-2.5pp1.7%-0.7pp1.9%-0.6pp1.1%-2.5pp2.6%-0.4pp2.5%+0.1pp2.5%+1.2pp3.7%-2.8pp
Current Ratio1.47-0.7x1.45-0.5x1.67-0.3x1.61-0.5x2.13-0.1x1.96-0.3x2.000.0x2.08+0.1x
Debt-to-Equity0.52-0.2x0.55-0.2x0.54-0.3x0.55-0.2x0.72-0.1x0.760.0x0.800.0x0.76-0.1x
Asset Turnover0.250.0x0.230.0x0.230.0x0.240.0x0.240.0x0.250.0x0.260.0x0.270.0x
FCF Margin3.8%-16.6pp3.5%+3.4pp6.7%+1.8pp17.2%+6.0pp20.4%+5.1pp0.1%-12.9pp4.9%-0.4pp11.2%+5.0pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Cabot Corporation CBT FY2025 $3.7B $331.0M 8.9% $3.9B 59/100
Sensient Technology Corporation SXT FY2025 $1.6B $134.5M 8.3% $5.5B 60/100
Hawkins Inc HWKN FY2026 $1.1B $81.5M 7.5% $2.7B 65/100
H.B. Fuller Company FUL FY2025 $3.5B $152.0M 4.4% $2.7B 52/100
Balchem Corporation BCPC FY2025 $1.0B $154.8M 14.9% $5.4B 58/100

Frequently Asked Questions

What is Cabot Corporation's annual revenue?

Cabot Corporation (CBT) reported $3.7B in total revenue for fiscal year 2025. This represents a -7.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cabot Corporation's revenue growing?

Cabot Corporation (CBT) revenue declined by 7.0% year-over-year, from $4.0B to $3.7B in fiscal year 2025.

Is Cabot Corporation profitable?

Yes, Cabot Corporation (CBT) reported a net income of $331.0M in fiscal year 2025, with a net profit margin of 8.9%.

Cabot Corporation (CBT) reported diluted earnings per share of $6.02 for fiscal year 2025. This represents a -10.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cabot Corporation (CBT) had EBITDA of $775.0M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Cabot Corporation (CBT) had $258.0M in cash and equivalents against $856.0M in long-term debt.

Cabot Corporation (CBT) had a gross margin of 25.3% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Cabot Corporation (CBT) had an operating margin of 16.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Cabot Corporation (CBT) had a net profit margin of 8.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Cabot Corporation (CBT) paid $1.76 per share in dividends during fiscal year 2025.

Cabot Corporation (CBT) has a return on equity of 21.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Cabot Corporation (CBT) generated $391.0M in free cash flow during fiscal year 2025. This represents a -13.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Cabot Corporation (CBT) generated $665.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Cabot Corporation (CBT) had $3.8B in total assets as of fiscal year 2025, including both current and long-term assets.

Cabot Corporation (CBT) invested $274.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Cabot Corporation (CBT) invested $59.0M in research and development during fiscal year 2025.

Yes, Cabot Corporation (CBT) spent $168.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Cabot Corporation (CBT) had 53M shares outstanding as of fiscal year 2025.

Cabot Corporation (CBT) had a current ratio of 1.61 as of fiscal year 2025, which is generally considered healthy.

Cabot Corporation (CBT) had a debt-to-equity ratio of 0.55 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Cabot Corporation (CBT) had a return on assets of 8.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Cabot Corporation (CBT) trades at 20.4x earnings, its market capitalization divided by net income of $190.0M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.9B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cabot Corporation (CBT) trades at 1.1x sales, its market capitalization divided by revenue of $3.6B revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.9B as of Oct 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Cabot Corporation (CBT) has an Altman Z-Score of 3.39, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Cabot Corporation (CBT) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Cabot Corporation (CBT) has an earnings quality ratio of 2.01x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Cabot Corporation (CBT) has an interest coverage ratio of 8.17x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Cabot Corporation (CBT) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top